How The Pulmonx (LUNG) Narrative Is Resetting Around Execution Risks And Fair Value Assumptions [Yahoo! Finance]
Pulmonx Corporation (LUNG)
US:NASDAQ Investor Relations:
investor.prolunginc.com/investor-relations
Company Research
Source: Yahoo! Finance
Pulmonx's fair value estimate has been reset from US$5.75 to about US$5.17 per share, putting a fresh spotlight on what analysts are building into their models. Recent commentary frames this lower target as a recalibration tied to execution issues, with Q4 described as largely in line and management outlining specific fixes and a renewed focus on core fundamentals. As you read on, you will see how this evolving narrative shapes the key questions to watch and how to track the story from here. Stay updated as the Fair Value for Pulmonx shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Pulmonx. What Wall Street Has Been Saying ?? Bullish Takeaways Canaccord, through analyst William Plovanic, maintained a positive stance on Pulmonx even after resetting its price target to US$5. This signals that the firm still sees value at current levels. Q4 was described by Canaccord as largely in line, which can give you
Show less
Read more
Impact Snapshot
Event Time:
LUNG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUNG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUNG alerts
High impacting Pulmonx Corporation news events
Weekly update
A roundup of the hottest topics
LUNG
News
- Pulmonx (LUNG) had its price target lowered by Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.MarketBeat
- Pulmonx (LUNG) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $14.00 price target on the stock.MarketBeat
- Pulmonx Corp (LUNG) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Sales Force ... [Yahoo! Finance]Yahoo! Finance
- Pulmonx Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Pulmonx (LUNG) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
LUNG
Earnings
- 3/4/26 - Beat
LUNG
Analyst Actions
- 3/5/26 - Canaccord Genuity
LUNG
Sec Filings
- 3/10/26 - Form S-8
- 3/10/26 - Form 10-K
- 3/9/26 - Form SCHEDULE
- LUNG's page on the SEC website